A detailed history of Bruce G. Allen Investments, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 40 shares of CTLT stock, worth $2,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 91 56.04%
Holding current value
$2,416
Previous $5.14 Million 56.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$53.58 - $57.02 $2,732 - $2,908
-51 Reduced 56.04%
40 $2.25 Million
Q1 2024

Apr 10, 2024

BUY
$42.56 - $59.82 $2,170 - $3,050
51 Added 127.5%
91 $5.14 Million
Q4 2023

Jan 10, 2024

BUY
$32.18 - $46.57 $1,287 - $1,862
40 New
40 $1.8 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.